Avalyn Pharma Inc.
NASDAQAvalyn Pharma enters the second half of June with an unusual split: short sellers are piling in at the fastest pace in months, while major institutional backers are adding aggressively at lower prices. The short-selling story is the sharpest data point this week. Shares short have climbed roughly 61% over the past week — from around 736,000 to just under 1.18 million — a pace that…
AVLN short interest
Full pulse commentary is for ORTEX subscribers. The live data picture for AVLN below stays open — short interest, options flow, signals, and historical context.
Sign up free to read pulse →Short interest % of float, cost to borrow, utilization, and put/call ratio for AVLN are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 18 Jun 2026
Avalyn Pharma enters the second half of June with an unusual split: short sellers are piling in at the fastest pace in months, while major institutional backers are adding aggressively at lower prices. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AVLN — free to start on ORTEX.
Sign up for free →Open AVLN on ORTEX